1-methyl-2-(3-pyridyl)azetidine has been researched along with Paralysis in 1 studies
*Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abood, LG; Banerjee, S; Lu, X | 1 |
1 other study(ies) available for 1-methyl-2-(3-pyridyl)azetidine and Paralysis
| Article | Year |
|---|---|
Receptor binding characteristics of a 3H-labeled azetidine analogue of nicotine.
Topics: Animals; Azetidines; Azetines; Binding, Competitive; Brain Chemistry; Carbachol; Cell Membrane; Choline; Kinetics; Nicotine; Paralysis; Protein Binding; Psychotropic Drugs; Rats; Receptors, Nicotinic; Thermodynamics | 1987 |